Malaria still presents as a major health problem in Indonesia Background: and specifically in East Kalimantan. One common finding in malaria is thrombocytopenia, the mechanism of which is still unclear. Several studies have suggested some mechanisms, one of which is splenomegaly. This study aimed to discover the association between thrombocytopenia and splenomegaly of malaria patients in East Kalimantan.
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One common finding in malaria is decreased platelet count or so-called thrombocytopenia. This laboratory finding is often confused with other infectious diseases, especially dengue infection in which thrombocytopenia is a major diagnostic parameter. There are many studies that demonstrate thrombocytopenia in malaria patients [3] [4] [5] , and this is found in both infection with Plasmodium falciparum and Plasmodium vivax. The results from our previous study demonstrated that from 1041 malaria patients in East Kalimantan, 85% presented with thrombocytopenia of varying degrees 4 . Therefore, thrombocytopenia has been suggested as one important diagnostic parameter in malaria. The mechanism of thrombocytopenia in malaria is still unclear. Several theories, such as mechanical trapping of thrombocytes inside the spleen and immune response that attacks thrombocytes, has been proposed 5 . A study by Coelho et al. found that platelet phagocytosis may contribute to thrombocytopenia in vivax malaria 6 .
Splenomegaly is also one common clinical finding in malaria patients. The spleen is part of the reticuloendothelial system, which becomes active in order to get rid of plasmodium-infected erythrocytes. Splenomegaly can also contribute to increased destruction of thrombocytes due to mechanical trapping. Therefore, the aim of the present study was to determine the association of thrombocytopenia with splenomegaly in malaria patients in East Kalimantan.
Methods

Study design and participants
This study was a cross-sectional retrospective study. This study was approved by the Ethical Committee for Health Research at Abdul Wahab Syahranie Hospital Samarinda, East Kalimantan (approval number 124/KEPK-AWS/V/2018). This ethical approval also covers the research conducted in all hospitals included in our study. Patient consent for the use of their data records was waived by the ethical committee due to the retrospective nature of the study.
Data collection
Data were collected between June and August 2018 from the medical records of patients with malaria during the period of January 2015 to July 2018. Clinical and laboratory data of both outpatients and inpatients diagnosed with malaria from four major hospitals in East Kalimantan was collected. The hospitals were: Abdul Wahab Sjahranie Hospital in Samarinda, Aji Putri Botung Hospital in Penajam Paser Utara, Abdul Rivai Hospital in Tanjung Redeb, and Panglima Sebaya Hospital in Tanah Grogot.
All patients with malaria, both paediatric and adult patients, were included in the study. Patients were excluded from the study if the necessary data were incomplete or patients discharged themselves during treatment.
In order to collect data, first, the hospital's database was searched for patients diagnosed with malaria. Second, after identifying these patients, the relevant medical records were retrieved which contained age, gender, type of Plasmodium, thrombocyte count, presence of splenomegaly.
Data analysis
For descriptive data, we described patients' characteristics that include age, sex, type of Plasmodium, and thrombocyte count on the first day admission. The association between thrombocytopenia and splenomegaly was analyzed by Chisquare test using SPSS 23.0 software. Results were considered statistically significant if p<0.05.
Results
Our study identified a total of 215 malaria patients from January 2015 to July-2018 in five hospitals in East Kalimantan. There were 189 male patients (87.9%) and 26 female patients (12.1%). From 215 malaria patients ( Table 1) .
The association of thrombocytopenia with splenomegaly in malaria patients shown in Table 2 . There were 11 patients with splenomegaly and 204 patients without splenomegaly. There was no association between the presence of splenomegaly and thrombocytopenia in these malaria patients (p=0.661). 
Discussion
We found that the incidence of malaria was higher in males than females in this group of patients, and the parasite infecting the majority of patients was Plasmodium vivax (42.0% A study by Hanson et al. in Vietnam found that thrombocytopenia was a marker of disease severity in adults with Plasmodium falciparum infection, but has limited utility in prognostication, triage and management 9 . On the other hand, Rao et al. in India found that severe thrombocytopenia showed positive correlation with complicated malaria and become a good predictor for poor prognosis 10 .
Indeed, splenomegaly is a hallmark of malaria, but the result of this study found that only 11 patients (5.1%) showed splenomegaly. In India, Gupta et al. found that only 20% malaria patients had splenomegaly, but there are no information about thrombocyte count in those malaria patients with splenomegaly 11 .
In our study, we describe the thrombocyte count in malaria patients with splenomegaly. We found that there was no association between thrombocytopenia with splenomegaly (p=0.611). Therefore, we propose that thrombocytopenia is not caused by the mechanical trapping of thrombocytes in the spleen. This result suggests another mechanism of thrombocytopenia that involves immune process, as proposed by Coelhoe et al. in 2013 6 . Until now, the definitive mechanism of thrombocytopenia in malaria was unclear; however, some factors that contribute to thrombocytopenia have been reported, such as decreased thrombopoiesis, peripheral destruction induced by P. falciparum and disseminated intravascular coagulation 12 .
This study has its limitations. Different types of automatic haematology analysers were used in the hospitals and this might contribute to variations in thrombocyte count. Therefore, we suggest the use of a single haematology analyser across hospitals to improve accuracy. In addition, we did not exclude other causes of thrombocytopenia that could coexist with malaria infection, such as viral infection and autoimmune diseases, which would be require to further validate our findings. Finally, the examination of splenomegaly was conducted by different physicians, which might contribute to subjective factors in determining splenomegaly, such as physician's expertise and thoroughness, especially in cases with minor or subclinical splenomegaly.
Overall, we conclude that thrombocytopenia is not associated with splenomegaly in this set of malaria patients.
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